Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Sapphire NC ULTRA Coronary Dilatation Catheter

K-Number: K233499 · 2024-08-16

ApplicantOrbusNeich Medical (Shenzhen) Co., Ltd.
Decision Date2024-08-16
Product CodeLOX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Sapphire NC ULTRA Coronary Dilatation Catheter is a medical device manufactured by OrbusNeich Medical (Shenzhen) Co., Ltd.. It received FDA 510(k) clearance on 2024-08-16 under approval number K233499. The device is classified under product code LOX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Sapphire NC ULTRA Coronary Dilatation Catheter?

Sapphire NC ULTRA Coronary Dilatation Catheter is a medical device that received FDA 510(k) clearance on 2024-08-16. It is manufactured by OrbusNeich Medical (Shenzhen) Co., Ltd.. The 510(k) number is K233499.

When was Sapphire NC ULTRA Coronary Dilatation Catheter approved by the FDA?

Sapphire NC ULTRA Coronary Dilatation Catheter received FDA 510(k) clearance on 2024-08-16, under approval number K233499.

What company makes Sapphire NC ULTRA Coronary Dilatation Catheter?

Sapphire NC ULTRA Coronary Dilatation Catheter is manufactured by OrbusNeich Medical (Shenzhen) Co., Ltd..

What is the FDA product code for Sapphire NC ULTRA Coronary Dilatation Catheter?

The FDA product code for Sapphire NC ULTRA Coronary Dilatation Catheter is LOX.

Related Clinical Trials

NCT04647253 A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) ACTIVE_NOT_RECRUITING NCT06492174 A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort ACTIVE_NOT_RECRUITING NCT06662500 FORWARD CAD IDE Study RECRUITING NCT01630707 Evaluation of the Delivery of Optimized Supersaturated Oxygen Therapy to Treat Patients With an Acute Heart Attack COMPLETED NCT06795763 Acolyte CTO-PCI Study: Imaging and Catheter System to Treat Patients With Coronary Chronic Total Occlusion, Who Have Persistent Symptoms Following Medical Therapy and Are Undergoing Percutaneous Coronary Interventional Procedures ENROLLING_BY_INVITATION NCT05731700 CVT-ISR First in Human Trial for Coronary In-Stent Restenosis COMPLETED

Other Devices by OrbusNeich Medical (Shenzhen) Co., Ltd.

K202231JADE K201794Jade K211807Sapphire NC 24 K233505Sapphire ULTRA Coronary Dilatation Catheter K241025JADE PLUS PTA Balloon Dilatation Catheter K231608Teleport XT Microcatheter

View all 10 devices →

Related Devices (Code: LOX)

K163200Maverick XL Percutaneous Transluminal Coronary Angioplasty Monorail Dilatation CatheteBoston Scientific Corporation K163174Emerge PTCA Dilatation CatheterBoston Scientific Corporation K160985Pantera ProBiotronik, Inc. K162209Sapphire NC PlusOrbusneich Medical, Inc. K153742Apollo Balloon Dilatation CatheterBrosmed Medical Co., Ltd. K160961Mozec NC-Rx PTCA Baloon Dilatation CatheterMeril Life Sciences Private Limited

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑